Compare EXK & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXK | BHC |
|---|---|---|
| Founded | 1981 | N/A |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.0B |
| IPO Year | 2004 | 1996 |
| Metric | EXK | BHC |
|---|---|---|
| Price | $8.66 | $4.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $13.94 | $8.00 |
| AVG Volume (30 Days) | ★ 6.6M | 2.0M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,724,000,000.00 |
| Revenue This Year | $69.59 | $4.61 |
| Revenue Next Year | $17.61 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.75 | $4.57 |
| 52 Week High | $15.15 | $8.69 |
| Indicator | EXK | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 45.56 | 32.85 |
| Support Level | $8.47 | N/A |
| Resistance Level | $10.33 | $6.31 |
| Average True Range (ATR) | 0.57 | 0.21 |
| MACD | 0.04 | -0.04 |
| Stochastic Oscillator | 48.45 | 23.84 |
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has three operating mining segments namely; Guanacevi and Terronera in Mexico, and Minera Kolpa in Peru. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.